Swiss Health Web
EMH Schweizerischer Ärzteverlag AG
Farnsburgerstrasse 8
CH-4132 Muttenz
+41 (0)61 467 85 55
support@swisshealthweb.ch
www.swisshealthweb.ch
Published on 29.07.2021
The SARS-CoV-2 pandemic influenced access to the psychiatric ED.
Feature | 2019 | 2020 | Total | Test statistic | p-value |
---|---|---|---|---|---|
Number of visits | 349 | 158 | 507 | N/A | <0.001* |
Gender, n (%) | |||||
Female | 225 (64.5%) | 81 (51.3%) | 306 (60.4%) | χ2(1) = 7.93† | 0.005† |
Male | 124 (35.5%) | 77 (48.7%) | 201 (39.6%) | ||
Age (years), mean ± SD | 48.8 ± 17.5 | 48.6 ± 19.7 | 48.7 ± 18.2 | t(273.5) = 0.080‡ | 0.93‡ |
Assessment orders, n (%) | 11 (3.2%) | 19 (12.0%) | 30 (5.9%) | χ2(1) = 15.3† | <0.001† |
Hospitalisations, n (%) | 57 (16.3%) | 28 (17.7%) | 85 (16.8%) | χ2(1) = 0.15† | 0.70† |
Compulsory hospitalisations, n (% of all hospitalisations) | 9 (15.8%) | 9 (33.3%) | 18 (21.4%) | χ2(1) = 3.35† | 0.067† |
Suicide attempts, n (%) | 22 (6.3%) | 16 (10.1%) | 38 (7.5%) | χ2(1) = 2.29† | 0.13† |
2019 | 2020 | ||
---|---|---|---|
Diagnosis | % | Diagnosis | % |
(F10) Mental and behavioral disorders due to use of alcohol | 18.2% | (F19) Mental and behavioral disorders due to multiple drug use and use of other psychoactive substances | 5.3% |
(F20) Schizophrenia | 36.4% | (F20) Schizophrenia | 26.3% |
(F29) Unspecified nonorganic psychosis | 18.2% | (F25) Schizoaffective disorders | 5.3% |
(F33) Recurrent depressive disorder | 9.1% | (F29) Unspecified nonorganic psychosis | 21.0% |
(F70) Mild mental retardation | 18.2% | (F31) Bipolar disorder | 26.3% |
(F32) Depressive episode | 5.3% | ||
(F60) Specific personality disorders | 5.3% | ||
(F71) Moderate mental retardation | 5.3% |
Diagnosis | 2019 | 2020 |
---|---|---|
(F00–F09) Organic, including symptomatic, mental disorders, n (%) | 23 (6.6%) | 15 (9.5%) |
(F03) Unspecified dementia | 12 | 10 |
(F05) Delirium, not induced by alcohol and other psychoactive substances | 10 | 4 |
(F07) Personality and behavioural disorder due to brain disease, damage and dysfunction | 1 | 1 |
(F10–F19) Mental and behavioural disorders due to psychoactive substance use*, n (%) | 16 (4.6%)* | 15 (9.5%)* |
(F10) Mental and behavioural disorders due to use of alcohol | 9 | 5 |
(F11) Mental and behavioural disorders due to use of opioids | 2 | 2 |
(F13) Mental and behavioural disorders due to use of sedatives or hypnotics | 1 | 3 |
(F14) Mental and behavioural disorders due to use of cocaine | 0 | 2 |
(F19) Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances | 4 | 3 |
(F20–F29) Schizophrenia, schizotypal and delusional disorders, n (%) | 47 (13.5%) | 27 (17.1%) |
(F20) Schizophrenia | 19 | 13 |
(F22) Persistent delusional disorders | 1 | 0 |
(F25) Schizoaffective disorders | 12 | 8 |
(F29) Unspecified nonorganic psychosis | 15 | 6 |
(F30–F39) Mood [affective] disorders*, n (%) | 149 (47.2%)* | 44 (27.9%)* |
(F31) Bipolar affective disorder | 34 | 9 |
(F32) Depressive episode | 39 | 7 |
(F33) Recurrent depressive disorder | 64 | 28 |
(F34) Persistent mood [affective] disorders | 12 | 0 |
(F40–F48) Neurotic, stress-related and somatoform disorders, n (%) | 65 (18.6%) | 25 (15.8%) |
(F40) Phobic anxiety disorders | 3 | 0 |
(F41) Other anxiety disorders | 23 | 17 |
(F42) Obsessive - compulsive disorder | 1 | 0 |
(F43) Reaction to severe stress, and adjustment disorders | 36 | 8 |
(F45) Somatoform disorders | 2 | 0 |
(F50–F59) Behavioural syndromes associated with physiological disturbances and physical factors, n (%) | 0 (0.0%) | 1 (0.6%) |
(F50) Eating disorders | 0 | 1 |
(F60–F69) Disorders of adult personality and behaviour, n (%) | 24 (6.9%) | 9 (5.7%) |
(F60) Specific personality disorders | 13 | 5 |
(F63) Habit and impulse disorders | 5 | 2 |
(F69) Unspecified disorder of adult personality and behaviour | 6 | 2 |
(F70–F79) Mental retardation, n (%) | 13 (3.7%) | 3 (1.9%) |
(F70) Mild mental retardation | 13 | 1 |
(F71) Moderate mental retardation | 0 | 2 |
(G47) Sleep Disorders*, n (%) | 5 (1.4%)* | 7 (4.4%)* |
Non-psychiatric diagnosis*, n (%) | 7 (2.0%)* | 12 (7.6%)* |
2019 | 2020 | ||
---|---|---|---|
Diagnosis | % | Diagnosis | % |
(F13) Mental and behavioural disorders due to use of sedatives or hypnotics | 4.5% | (F07) Personality and behavioural disorder due to brain disease, damage and dysfunction | 6.3% |
(F31) Bipolar disorder | 9.1% | (F10) Mental and behavioural disorders due to use of alcohol | 12.5% |
(F32) Depressive episode | 18.2% | (F13) Mental and behavioural disorders due to use of sedatives or hypnotics | 12.5% |
(F33) Recurrent depressive disorder | 22.7% | (F32) Depressive episode | 6.3% |
(F34) Persistent mood [affective] disorders | 4.5% | (F33) Recurrent depressive disorder | 12.5% |
(F43) Reaction to severe stress, and adjustment disorders | 13.6% | (F43) Reaction to severe stress, and adjustment disorders | 12.5% |
(F60) Specific personality disorders | 18.2% | (F60) Specific personality disorders | 12.5% |
(F69) Unspecified disorder of adult personality and behaviour | 4.5% | (F63) Habit and impulse disorders | 12.5% |
(F70) Mild mental retardation | 4.5% | (F69) Unspecified disorder of adult personality and behaviour | 6.3% |
Other non-psychiatric | 6.3% |
Published under the copyright license.
"Attribution - Non-Commercial - NoDerivatives 4.0"
No commercial reuse without permission.
See: emh.ch/en/emh/rights-and-licences/